Topic: Affymax Inc.
SILVER SPRING, Maryland (Reuters) - A new Affymax Inc drug won expert backing to treat anemia in patients with chronic kidney disease who are on dialysis.A Food and Drug Administration advisory panel voted 15-1 on Wednesday, with one abstention, that peginesatide's benefits ...
Affymax shares fall to lowest point in over 3 years on anemia drug's late-stage safety dataShares of Affymax fell to their lowest point in more than three years on Monday after the company reported safety data from ongoing late-stage studies of its ...
Affymax's 3rd-quarter loss narrows on larger payment from anemia drug partnershipBiotechnology company Affymax Inc. said Wednesday its third-quarter loss narrowed on a boost in payments from its partner Takeda Pharmaceutical on the anemia drug candidate Hematide.The company lost $18.4 million, or 97 ...
From Around the Web
Video Gallery
-
KTCC, MDVN, STX, BVSN - Stock Charts ...
02/01/12 - The market had another wonderful on Wednesday ...2012-02-02 -
DNDN, BVSN, CIE, RAX - Stock Charts ...
02/06/12 - There are so many longs that we ...2012-02-07 -
ZNGA, AMLN, YOKU, RAX - Stock Charts ...
02/02/12 - Despite the fact that the market had ...2012-02-03
